Endocrine Disruption

Endocrine disruption has been recognized as a priority endpoint in safety evaluation of chemicals and consumer products. Endocrine disrupting compounds (EDCs) are being classified as substances of very high concern and regulations to restrict their use are being installed world-wide. EDC effects are hard to predict and are best tested using bioassays.

CALUX® methods

Available for endocrine disruption screening

To avoid animal studies BDS has developed a range of assays that allow screening and safety assessment of chemicals and complex mixtures including consumer products in a rapid and cost-effective manner.

Learn more